Literature DB >> 22447176

Acute viral hepatitis in the United States-Mexico border region: data from the Border Infectious Disease Surveillance (BIDS) Project, 2000-2009.

Philip R Spradling1, Jian Xing, Alba Phippard, Maureen Fonseca-Ford, Sonia Montiel, Norma Luna Guzmán, Roberto Vázquez Campuzano, Gilberto Vaughan, Guo-liang Xia, Jan Drobeniuc, Saleem Kamili, Ricardo Cortés-Alcalá, Stephen H Waterman.   

Abstract

Little is known about the characteristics of acute viral hepatitis cases in the United States (US)-Mexico border region. We analyzed characteristics of acute viral hepatitis cases collected from the Border Infectious Disease Surveillance Project from January 2000-December 2009. Over the study period, 1,437 acute hepatitis A, 311 acute hepatitis B, and 362 acute hepatitis C cases were reported from 5 Mexico and 2 US sites. Mexican hepatitis A cases most frequently reported close personal contact with a known case, whereas, US cases most often reported cross-border travel. Injection drug use was common among Mexican and US acute hepatitis B and C cases. Cross-border travel during the incubation period was common among acute viral hepatitis cases in both countries. Assiduous adherence to vaccination and prevention guidelines in the US is needed and strategic implementation of hepatitis vaccination and prevention programs south of the border should be considered.

Entities:  

Mesh：

Year:  2013        PMID： 22447176      PMCID： PMC6515900          DOI： 10.1007/s10903-012-9604-8

Source DB:  PubMed          Journal:  J Immigr Minor Health        ISSN： 1557-1912


  25 in total

1.  Infectious disease morbidity in the US region bordering Mexico, 1990-1998.

Authors:  T J Doyle; R T Bryan
Journal:  J Infect Dis       Date:  2000-09-27       Impact factor: 5.226

Review 2.  Prevention of hepatitis A with the hepatitis A vaccine.

Authors:  Allen S Craig; William Schaffner
Journal:  N Engl J Med       Date:  2004-01-29       Impact factor: 91.245

3.  The Pachuco mark and similar tattoos.

Authors:  Daniel J Teague; Daniel J Sheehan
Journal:  South Med J       Date:  2009-01       Impact factor: 0.954

4.  Hepatitis a molecular epidemiology in the United States, 1996-1997: sources of infection and implications of vaccination policy.

Authors:  Omana V Nainan; Gregory L Armstrong; Xiao-Hua Han; Ian Williams; Beth P Bell; Harold S Margolis
Journal:  J Infect Dis       Date:  2005-02-11       Impact factor: 5.226

5.  Preventing and controlling tuberculosis along the U.S.-Mexico border.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2001-01-19

Review 6.  United States epidemiology of hepatitis A: influenced by immigrants visiting friends and relatives in Mexico?

Authors:  Elaine C Jong
Journal:  Am J Med       Date:  2005-10       Impact factor: 4.965

7.  Hepatitis A in Latin America: a changing epidemiologic pattern.

Authors:  R Tapia-Conyer; J I Santos; A M Cavalcanti; E Urdaneta; L Rivera; A Manterola; M Potin; R Ruttiman; J Tanaka Kido
Journal:  Am J Trop Med Hyg       Date:  1999-11       Impact factor: 2.345

8.  [Epidemiologic and situational panorama of hepatitis C in Mexico].

Authors:  Lizeth Vera de León; Jesús Alberto Juárez Navarro; Marcelino Díaz Gómez; Jorge Méndez Navarro; Ruby Ann Chirino Sprung; Margarita Dehesa Violante; Leticia Casillas Davila; María Teresa Rizo Robles; Rocio Torres Ibarra; Carlos Cano Domínguez; Jesús Nava Estrada; Mayra Ramos Gómez; María Elena Hernández; Samuel Wong González; Monica Félix Tamayo; M Del Carmen Corona Lechuga; Alma Rosa Zárate Negrete; Magdalena Rangel Jiménez; Heriberto Rodríguez Hernández; Valentin González Ortiz; Martha Patricia Tirado Estrella; María Los de Angeles Villanueva Carreto; Raymundo Orta Flores; José Luis Manteca Argumedo; Isidro Vázquez Avila; Juan González Macias; Omar Razcón Hernández; Pastora Torres López; Carlos Bazán Pérez
Journal:  Rev Gastroenterol Mex       Date:  2005 Jan-Mar

9.  Hepatitis A in Hispanic children who live along the United States-Mexico border: the role of international travel and food-borne exposures.

Authors:  Michelle Weinberg; Jackie Hopkins; Leigh Farrington; Louise Gresham; Michele Ginsberg; Beth P Bell
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124

10.  The U.S.-Mexico Border Infectious Disease Surveillance project: establishing bi-national border surveillance.

Authors:  Michelle Weinberg; Stephen Waterman; Carlos Alvarez Lucas; Veronica Carrion Falcon; Pablo Kuri Morales; Luis Anaya Lopez; Chris Peter; Alejandro Escobar Gutiérrez; Ernesto Ramirez Gonzalez; Ana Flisser; Ralph Bryan; Enrique Navarro Valle; Alfonso Rodriguez; Gerardo Alvarez Hernandez; Cecilia Rosales; Javier Arias Ortiz; Michael Landen; Hugo Vilchis; Julie Rawlings; Francisco Lopez Leal; Luis Ortega; Elaine Flagg; Roberto Tapia Conyer; Martin Cetron
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883
View more
  3 in total

1.  Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California.

Authors:  Danielle Horyniak; Karla D Wagner; Richard F Armenta; Jazmine Cuevas-Mota; Erik Hendrickson; Richard S Garfein
Journal:  Int J Drug Policy       Date:  2017-07-03

2.  Examining the gender composition of drug injecting initiation events: A mixed methods investigation of three North American contexts.

Authors:  Meyers Sa; Rafful C; Mittal Ml; Smith Lr; Tirado-Muñoz J; Jain S; Sun X; Garfein Rs; Strathdee Sa; DeBeck K; Hayashi K; McNeil R; Milloy Mj; Olding M; Guise A; Werb D; Scheim Ai
Journal:  Int J Drug Policy       Date:  2020-12-11

3.  Epidemiological surveillance of land borders in North and South America: a case study.

Authors:  Robson Bruniera-Oliveira; Marco Aurélio Pereira Horta; Aiden Varan; Sonia Montiel; Eduardo Hage Carmo; Stephen H Waterman; José Fernando de Souza Verani
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-11-06       Impact factor: 1.846
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.